Societal CDMO, Inc.

NasdaqCM:SCTL Stock Report

Market Cap: US$116.3m

This company has been acquired

The company may no longer be operating, as it has been acquired. Find out why through their latest events.

Societal CDMO Balance Sheet Health

Financial Health criteria checks 3/6

Societal CDMO has a total shareholder equity of $58.7M and total debt of $37.1M, which brings its debt-to-equity ratio to 63.2%. Its total assets and total liabilities are $153.5M and $94.8M respectively.

Key information

63.2%

Debt to equity ratio

US$37.10m

Debt

Interest coverage ration/a
CashUS$8.10m
EquityUS$58.66m
Total liabilitiesUS$94.81m
Total assetsUS$153.47m

Recent financial health updates

Is Societal CDMO (NASDAQ:SCTL) Weighed On By Its Debt Load?

Dec 23
Is Societal CDMO (NASDAQ:SCTL) Weighed On By Its Debt Load?

Does Societal CDMO (NASDAQ:SCTL) Have A Healthy Balance Sheet?

May 31
Does Societal CDMO (NASDAQ:SCTL) Have A Healthy Balance Sheet?

Recent updates

Societal CDMO, Inc.'s (NASDAQ:SCTL) Price Is Right But Growth Is Lacking After Shares Rocket 38%

Feb 10
Societal CDMO, Inc.'s (NASDAQ:SCTL) Price Is Right But Growth Is Lacking After Shares Rocket 38%

Is There An Opportunity With Societal CDMO, Inc.'s (NASDAQ:SCTL) 46% Undervaluation?

Feb 02
Is There An Opportunity With Societal CDMO, Inc.'s (NASDAQ:SCTL) 46% Undervaluation?

Is Societal CDMO (NASDAQ:SCTL) Weighed On By Its Debt Load?

Dec 23
Is Societal CDMO (NASDAQ:SCTL) Weighed On By Its Debt Load?

Does Societal CDMO (NASDAQ:SCTL) Have A Healthy Balance Sheet?

May 31
Does Societal CDMO (NASDAQ:SCTL) Have A Healthy Balance Sheet?

Societal CDMO signs two CDMO service agreements

Oct 20

Societal stock soars 20% on signing 2 manufacturing contracts

Sep 07

Societal CDMO estimates to receive up to $50M on real estates' sales

Aug 16

Societal CDMO, Lannett amend license and supply deal

Jul 12

These 4 Measures Indicate That Societal CDMO (NASDAQ:SCTL) Is Using Debt Extensively

Apr 29
These 4 Measures Indicate That Societal CDMO (NASDAQ:SCTL) Is Using Debt Extensively

Is Recro Pharma (NASDAQ:REPH) A Risky Investment?

Jan 06
Is Recro Pharma (NASDAQ:REPH) A Risky Investment?

Recro Pharma jumps 15% on Q1 result estimates beat

May 07

Would Shareholders Who Purchased Recro Pharma's (NASDAQ:REPH) Stock Year Be Happy With The Share price Today?

Feb 15
Would Shareholders Who Purchased Recro Pharma's (NASDAQ:REPH) Stock Year Be Happy With The Share price Today?

Financial Position Analysis

Short Term Liabilities: SCTL's short term assets ($53.5M) exceed its short term liabilities ($50.0M).

Long Term Liabilities: SCTL's short term assets ($53.5M) exceed its long term liabilities ($44.8M).


Debt to Equity History and Analysis

Debt Level: SCTL's net debt to equity ratio (49.4%) is considered high.

Reducing Debt: SCTL had negative shareholder equity 5 years ago, but is now positive and has therefore improved.


Balance Sheet


Cash Runway Analysis

For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.

Stable Cash Runway: SCTL has less than a year of cash runway based on its current free cash flow.

Forecast Cash Runway: Insufficient data to determine if SCTL has enough cash runway if its free cash flow continues to grow or shrink based on historical rates.


Discover healthy companies